[MAHSING] YoY Annualized Quarter Result on 31-Dec-2013 [#4]

Stock
[MAHSING] MAH SING GROUP BHD
Announcement Date
28-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 0.26%
YoY- 21.68%
Quarter Report
Latest QR
Upcoming QR
MAHSING's Result
MAHSING's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 2,957,617 3,108,506 2,904,723 2,005,596 1,775,260 1,570,696 1,110,108 17.72%
PBT 482,939 503,693 471,631 371,504 315,523 238,628 177,865 18.09%
Tax -122,627 -119,059 -116,721 -92,243 -83,755 -69,991 -49,462 16.32%
NP 360,312 384,634 354,910 279,261 231,768 168,637 128,403 18.74%
-
NP to SH 361,357 386,677 356,496 280,616 230,617 168,556 118,071 20.47%
-
Tax Rate 25.39% 23.64% 24.75% 24.83% 26.54% 29.33% 27.81% -
Total Cost 2,597,305 2,723,872 2,549,813 1,726,335 1,543,492 1,402,059 981,705 17.58%
-
Net Worth 3,648,444 3,195,677 2,242,370 1,799,489 1,236,193 1,072,704 914,634 25.90%
Dividend
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div 174,374 159,783 94,034 104,318 63,480 91,470 63,192 18.41%
Div Payout % 48.26% 41.32% 26.38% 37.17% 27.53% 54.27% 53.52% -
Equity
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 3,648,444 3,195,677 2,242,370 1,799,489 1,236,193 1,072,704 914,634 25.90%
NOSH 2,682,679 2,458,213 1,446,690 1,303,977 835,266 831,554 831,485 21.53%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 12.18% 12.37% 12.22% 13.92% 13.06% 10.74% 11.57% -
ROE 9.90% 12.10% 15.90% 15.59% 18.66% 15.71% 12.91% -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 110.25 126.45 200.78 153.81 212.54 188.89 133.51 -3.13%
EPS 13.47 15.73 18.35 21.52 27.61 20.27 14.20 -0.87%
DPS 6.50 6.50 6.50 8.00 7.60 11.00 7.60 -2.56%
NAPS 1.36 1.30 1.55 1.38 1.48 1.29 1.10 3.59%
Adjusted Per Share Value based on latest NOSH - 1,388,958
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 115.74 121.64 113.67 78.48 69.47 61.47 43.44 17.72%
EPS 14.14 15.13 13.95 10.98 9.02 6.60 4.62 20.47%
DPS 6.82 6.25 3.68 4.08 2.48 3.58 2.47 18.42%
NAPS 1.4277 1.2506 0.8775 0.7042 0.4838 0.4198 0.3579 25.90%
Price Multiplier on Financial Quarter End Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 1.43 1.45 2.26 2.26 2.07 2.10 1.84 -
P/RPS 1.30 1.15 1.13 1.47 0.97 1.11 1.38 -0.98%
P/EPS 10.62 9.22 9.17 10.50 7.50 10.36 12.96 -3.26%
EY 9.42 10.85 10.90 9.52 13.34 9.65 7.72 3.36%
DY 4.55 4.48 2.88 3.54 3.67 5.24 4.13 1.62%
P/NAPS 1.05 1.12 1.46 1.64 1.40 1.63 1.67 -7.43%
Price Multiplier on Announcement Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 28/02/17 26/02/16 16/02/15 28/02/14 27/02/13 28/02/12 25/02/11 -
Price 1.46 1.31 2.00 2.07 2.05 2.15 2.51 -
P/RPS 1.32 1.04 1.00 1.35 0.96 1.14 1.88 -5.71%
P/EPS 10.84 8.33 8.12 9.62 7.42 10.61 17.68 -7.82%
EY 9.23 12.01 12.32 10.40 13.47 9.43 5.66 8.48%
DY 4.45 4.96 3.25 3.86 3.71 5.12 3.03 6.60%
P/NAPS 1.07 1.01 1.29 1.50 1.39 1.67 2.28 -11.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment